Takeda Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 11.45% vs -8.15% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 130.74% vs -455.15% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,219,900.00",
          "val2": "1,094,541.00",
          "chgp": "11.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "411,430.00",
          "val2": "322,456.00",
          "chgp": "27.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "63,845.00",
          "val2": "43,649.00",
          "chgp": "46.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-111,902.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "113,256.00",
          "val2": "-368,408.00",
          "chgp": "130.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "203.60%",
          "val2": "144.90%",
          "chgp": "5.87%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -1.66% vs 7.45% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -240.67% vs -25.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,505,720.00",
          "val2": "4,581,551.00",
          "chgp": "-1.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,354,744.00",
          "val2": "1,388,939.00",
          "chgp": "-2.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "173,887.00",
          "val2": "186,976.00",
          "chgp": "-7.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-448,642.00",
          "val2": "-220,252.00",
          "chgp": "-103.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-152,125.00",
          "val2": "108,143.00",
          "chgp": "-240.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "140.60%",
          "val2": "137.00%",
          "chgp": "0.36%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

1,219,900.00

1,094,541.00

11.45%

Operating Profit (PBDIT) excl Other Income

411,430.00

322,456.00

27.59%

Interest

63,845.00

43,649.00

46.27%

Exceptional Items

0.00

-111,902.00

100.00%

Consolidate Net Profit

113,256.00

-368,408.00

130.74%

Operating Profit Margin (Excl OI)

203.60%

144.90%

5.87%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 11.45% vs -8.15% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 130.74% vs -455.15% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

4,505,720.00

4,581,551.00

-1.66%

Operating Profit (PBDIT) excl Other Income

1,354,744.00

1,388,939.00

-2.46%

Interest

173,887.00

186,976.00

-7.00%

Exceptional Items

-448,642.00

-220,252.00

-103.69%

Consolidate Net Profit

-152,125.00

108,143.00

-240.67%

Operating Profit Margin (Excl OI)

140.60%

137.00%

0.36%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is -1.66% vs 7.45% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -240.67% vs -25.00% in Mar 2025

All Annual Results